JP2024539106A5 - - Google Patents
Info
- Publication number
- JP2024539106A5 JP2024539106A5 JP2024523484A JP2024523484A JP2024539106A5 JP 2024539106 A5 JP2024539106 A5 JP 2024539106A5 JP 2024523484 A JP2024523484 A JP 2024523484A JP 2024523484 A JP2024523484 A JP 2024523484A JP 2024539106 A5 JP2024539106 A5 JP 2024539106A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163262732P | 2021-10-19 | 2021-10-19 | |
| US63/262,732 | 2021-10-19 | ||
| PCT/US2022/078177 WO2023069880A1 (en) | 2021-10-19 | 2022-10-14 | Novel methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024539106A JP2024539106A (ja) | 2024-10-28 |
| JP2024539106A5 true JP2024539106A5 (https=) | 2025-10-20 |
| JPWO2023069880A5 JPWO2023069880A5 (https=) | 2025-10-20 |
Family
ID=86058575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523484A Pending JP2024539106A (ja) | 2021-10-19 | 2022-10-14 | 新規方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240415832A1 (https=) |
| EP (1) | EP4419523A4 (https=) |
| JP (1) | JP2024539106A (https=) |
| KR (1) | KR20240089771A (https=) |
| CN (1) | CN118556058A (https=) |
| AU (1) | AU2022368858A1 (https=) |
| CA (1) | CA3235356A1 (https=) |
| IL (1) | IL312165A (https=) |
| MX (1) | MX2024004725A (https=) |
| WO (1) | WO2023069880A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3898580A4 (en) | 2018-12-17 | 2022-08-10 | Intra-Cellular Therapies, Inc. | SYNTHESIS OF CONDENSED GAMMA-CARBOLINES WITH SUBSTITUTED HETEROCYCLE |
| IL283963B2 (en) | 2018-12-17 | 2025-01-01 | Intra Cellular Therapies Inc | Synthesis of condensed gamma-carbolines and converted heterocycles |
| WO2020132605A1 (en) | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2024194263A1 (en) | 2023-03-17 | 2024-09-26 | Norwegian University Of Life Sciences | Serotonin 5ht2a receptor antagonist for use in treating side effects resulting form mu opioid receptor agonist overdose |
| WO2026011136A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2026011166A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Substituted heterocycles for use in the treatment of diseases involving the 5-ht2a receptor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7223742B2 (ja) * | 2017-07-26 | 2023-02-16 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| US20220160704A2 (en) * | 2018-08-08 | 2022-05-26 | Torralva Medical Therapeutics Llc | Compositions for opiate and opioid prevention and reversal, and methods of their use |
| WO2020132605A1 (en) * | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CN118105390A (zh) * | 2019-01-23 | 2024-05-31 | 细胞内治疗公司 | 治疗成瘾的方法 |
| CA3139168A1 (en) * | 2019-05-07 | 2020-11-12 | Nirsum Laboratories, Inc. | Opioid receptor antagonist prodrugs |
| EP4493560A4 (en) * | 2022-03-14 | 2026-03-18 | Intra Cellular Therapies Inc | ORGANIC COMPOUNDS |
-
2022
- 2022-10-14 MX MX2024004725A patent/MX2024004725A/es unknown
- 2022-10-14 KR KR1020247016018A patent/KR20240089771A/ko active Pending
- 2022-10-14 US US18/703,145 patent/US20240415832A1/en active Pending
- 2022-10-14 IL IL312165A patent/IL312165A/en unknown
- 2022-10-14 JP JP2024523484A patent/JP2024539106A/ja active Pending
- 2022-10-14 EP EP22884603.6A patent/EP4419523A4/en active Pending
- 2022-10-14 CA CA3235356A patent/CA3235356A1/en active Pending
- 2022-10-14 WO PCT/US2022/078177 patent/WO2023069880A1/en not_active Ceased
- 2022-10-14 AU AU2022368858A patent/AU2022368858A1/en active Pending
- 2022-10-14 CN CN202280084050.5A patent/CN118556058A/zh active Pending